Who published this market news?

TradingView published this market news item.

HeartSciences files 2026 Form 10-K, eyes proxy filing for proposed Fortitude merger

HeartSciences filed its fiscal 2026 Form 10-K and expects to file a preliminary proxy statement for the proposed Fortitude business combination.Key Highlights:Original SEC Filing: HeartSciences Inc. [ HSCS ] - 8-K - Jul. 23, 2026This is an AI-powered summary. It may contain inaccuracies. Consider v…

HeartSciences filed its fiscal 2026 Form 10-K and expects to file a preliminary proxy statement for the proposed Fortitude business combination.

Key Highlights:

Filed Annual Report on Form 10-K for fiscal year ended April 30, 2026; Form 10-K available on SEC and company websites.
Expect to file a preliminary proxy statement shortly in connection with proposed business combination with Fortitude.
Company says proposed merger offers significant opportunity for shareholders and could support continued MyoVista AI‑ECG advancement.
Fiscal 2026 earnings release and business update expected to be issued early next week following the proxy filing.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.